Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy

Abstract Objectives The aim of this study was to determine the incidence rate and clinical features of second primary pancreatic ductal carcinoma (SPPDC) in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma (PDC). Methods Data of patients undergoing R0 resection for PDC at a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2016-07, Vol.16 (4), p.615-620
Hauptverfasser: Ishida, Jun, Toyama, Hirochika, Matsumoto, Ippei, Asari, Sadaki, Goto, Tadahiro, Terai, Sachio, Nanno, Yoshihide, Yamashita, Azusa, Mizumoto, Takuya, Ueda, Yuki, Kido, Masahiro, Ajiki, Tetsuo, Fukumoto, Takumi, Ku, Yonson
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 620
container_issue 4
container_start_page 615
container_title Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
container_volume 16
creator Ishida, Jun
Toyama, Hirochika
Matsumoto, Ippei
Asari, Sadaki
Goto, Tadahiro
Terai, Sachio
Nanno, Yoshihide
Yamashita, Azusa
Mizumoto, Takuya
Ueda, Yuki
Kido, Masahiro
Ajiki, Tetsuo
Fukumoto, Takumi
Ku, Yonson
description Abstract Objectives The aim of this study was to determine the incidence rate and clinical features of second primary pancreatic ductal carcinoma (SPPDC) in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma (PDC). Methods Data of patients undergoing R0 resection for PDC at a single high-volume center were reviewed. SPPDC was defined as a tumor in the remnant pancreas after R0 resection for PDC, and SPPDC met at least one of the following conditions: 1) the time interval between initial pancreatectomy and development of a new tumor was 3 years or more; 2) the new tumor was not located in contact with the pancreatic stump. We investigated the clinical features and treatment outcomes of patients with SPPDC. Results This study included 130 patients who underwent surgical resection for PDC between 2005 and 2014. Six (4.6%) patients developed SPPDC. The cumulative 3- and 5-year incidence rates were 3.1% and 17.7%, respectively. Four patients underwent remnant pancreatectomy for SPPDC. They were diagnosed with the disease in stage IIA or higher and developed recurrence within 6 months after remnant pancreatectomy. One patient received carbon ion radiotherapy and survived 45 months. One patient refused treatment and died 19 months after the diagnosis of SPPDC. Conclusions The incidence rate of SPPDC is not negligible, and the cumulative 5-year incidence rate of SPPDC is markedly high. Post-operative surveillance of the remnant pancreas is critical for the early detection of SPPDC, even in long-term survivors after PDC resection.
doi_str_mv 10.1016/j.pan.2016.05.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1807078956</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1424390316300527</els_id><sourcerecordid>4131151651</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-86cae3ae75d7ed01bd390b3179bb670d228d9306c2e8614dd2ae7a695485514a3</originalsourceid><addsrcrecordid>eNp9ks9u1DAQxi0EoqXwAFyQJS5cNoztOH9AqoQqoEiVOBTOlmPPUi-Js9hJpX0zHo8Ju12kCvXkOfzmG8_3DWMvBRQCRPV2U2xtLCSVBegCQD1ip6KU5Uq1Qjw-1qBO2LOcNwBSCtE-ZSeylqqGtj1lv6_RjdHzbQqDTTtOgi6hnYLjfnaT7bmzyYU4DpaHyKcb5AmHaON0h2Zu1xOmYye6aRx2fD2mh8Te8cvw44a7eZh7Am6R1F3wGB0NIBFSnbjmO7Tp_wOesydr22d8cXjP2PdPH79dXK6uvn7-cvHhauU0yGnVVM6islhrX6MH0Xnyo1OibruuqsFL2fhWQeUkNpUovZfE2qrVZaO1KK06Y2_2uts0_poxT2YI2WHf24jjnI1ooIa6aXVF6Ot76GacU6Tf_aUoDK0kUWJPuTTmnHBtDt4bAWaJ1WwMrWqWWA1oQ7FSz6uD8twN6I8ddzkS8H4PIFlxGzCZ7MJipg-J_DJ-DA_Kn9_rdn2Iwdn-J-4w_9vCZGnAXC93tZyVqBSAlrX6A8VZyyI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1807424532</pqid></control><display><type>article</type><title>Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Ishida, Jun ; Toyama, Hirochika ; Matsumoto, Ippei ; Asari, Sadaki ; Goto, Tadahiro ; Terai, Sachio ; Nanno, Yoshihide ; Yamashita, Azusa ; Mizumoto, Takuya ; Ueda, Yuki ; Kido, Masahiro ; Ajiki, Tetsuo ; Fukumoto, Takumi ; Ku, Yonson</creator><creatorcontrib>Ishida, Jun ; Toyama, Hirochika ; Matsumoto, Ippei ; Asari, Sadaki ; Goto, Tadahiro ; Terai, Sachio ; Nanno, Yoshihide ; Yamashita, Azusa ; Mizumoto, Takuya ; Ueda, Yuki ; Kido, Masahiro ; Ajiki, Tetsuo ; Fukumoto, Takumi ; Ku, Yonson</creatorcontrib><description>Abstract Objectives The aim of this study was to determine the incidence rate and clinical features of second primary pancreatic ductal carcinoma (SPPDC) in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma (PDC). Methods Data of patients undergoing R0 resection for PDC at a single high-volume center were reviewed. SPPDC was defined as a tumor in the remnant pancreas after R0 resection for PDC, and SPPDC met at least one of the following conditions: 1) the time interval between initial pancreatectomy and development of a new tumor was 3 years or more; 2) the new tumor was not located in contact with the pancreatic stump. We investigated the clinical features and treatment outcomes of patients with SPPDC. Results This study included 130 patients who underwent surgical resection for PDC between 2005 and 2014. Six (4.6%) patients developed SPPDC. The cumulative 3- and 5-year incidence rates were 3.1% and 17.7%, respectively. Four patients underwent remnant pancreatectomy for SPPDC. They were diagnosed with the disease in stage IIA or higher and developed recurrence within 6 months after remnant pancreatectomy. One patient received carbon ion radiotherapy and survived 45 months. One patient refused treatment and died 19 months after the diagnosis of SPPDC. Conclusions The incidence rate of SPPDC is not negligible, and the cumulative 5-year incidence rate of SPPDC is markedly high. Post-operative surveillance of the remnant pancreas is critical for the early detection of SPPDC, even in long-term survivors after PDC resection.</description><identifier>ISSN: 1424-3903</identifier><identifier>EISSN: 1424-3911</identifier><identifier>DOI: 10.1016/j.pan.2016.05.003</identifier><identifier>PMID: 27237099</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Cancer ; Cancer therapies ; Carcinoma, Pancreatic Ductal - epidemiology ; Carcinoma, Pancreatic Ductal - pathology ; Carcinoma, Pancreatic Ductal - surgery ; Cellular biology ; Chemotherapy ; Disease ; Endocrinology &amp; Metabolism ; Endoscopy ; Female ; Funding ; Gastroenterology and Hepatology ; Humans ; Incidence ; Kaplan-Meier Estimate ; Lymphatic system ; Male ; Medical prognosis ; Metachronous ; Metastasis ; Middle Aged ; Mutation ; Neoplasm Recurrence, Local - epidemiology ; Neoplasms, Second Primary - epidemiology ; Neoplasms, Second Primary - pathology ; Neoplasms, Second Primary - surgery ; Pancreas ; Pancreas - diagnostic imaging ; Pancreas - pathology ; Pancreatectomy ; Pancreatic ductal carcinoma ; Pancreatic Neoplasms - epidemiology ; Pancreatic Neoplasms - pathology ; Pancreatic Neoplasms - surgery ; Pathology ; Patients ; Remnant pancreatic cancer ; Second primary ; Sensors ; Studies ; Surgery ; Survival Analysis ; Tomography, X-Ray Computed ; Treatment outcome ; Tumors</subject><ispartof>Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2016-07, Vol.16 (4), p.615-620</ispartof><rights>IAP and EPC</rights><rights>2016 IAP and EPC</rights><rights>Copyright © 2016 IAP and EPC. Published by Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Limited Jul/Aug 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-86cae3ae75d7ed01bd390b3179bb670d228d9306c2e8614dd2ae7a695485514a3</citedby><cites>FETCH-LOGICAL-c502t-86cae3ae75d7ed01bd390b3179bb670d228d9306c2e8614dd2ae7a695485514a3</cites><orcidid>0000-0001-8704-4353 ; 0000-0002-8665-2776</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27237099$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ishida, Jun</creatorcontrib><creatorcontrib>Toyama, Hirochika</creatorcontrib><creatorcontrib>Matsumoto, Ippei</creatorcontrib><creatorcontrib>Asari, Sadaki</creatorcontrib><creatorcontrib>Goto, Tadahiro</creatorcontrib><creatorcontrib>Terai, Sachio</creatorcontrib><creatorcontrib>Nanno, Yoshihide</creatorcontrib><creatorcontrib>Yamashita, Azusa</creatorcontrib><creatorcontrib>Mizumoto, Takuya</creatorcontrib><creatorcontrib>Ueda, Yuki</creatorcontrib><creatorcontrib>Kido, Masahiro</creatorcontrib><creatorcontrib>Ajiki, Tetsuo</creatorcontrib><creatorcontrib>Fukumoto, Takumi</creatorcontrib><creatorcontrib>Ku, Yonson</creatorcontrib><title>Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy</title><title>Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]</title><addtitle>Pancreatology</addtitle><description>Abstract Objectives The aim of this study was to determine the incidence rate and clinical features of second primary pancreatic ductal carcinoma (SPPDC) in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma (PDC). Methods Data of patients undergoing R0 resection for PDC at a single high-volume center were reviewed. SPPDC was defined as a tumor in the remnant pancreas after R0 resection for PDC, and SPPDC met at least one of the following conditions: 1) the time interval between initial pancreatectomy and development of a new tumor was 3 years or more; 2) the new tumor was not located in contact with the pancreatic stump. We investigated the clinical features and treatment outcomes of patients with SPPDC. Results This study included 130 patients who underwent surgical resection for PDC between 2005 and 2014. Six (4.6%) patients developed SPPDC. The cumulative 3- and 5-year incidence rates were 3.1% and 17.7%, respectively. Four patients underwent remnant pancreatectomy for SPPDC. They were diagnosed with the disease in stage IIA or higher and developed recurrence within 6 months after remnant pancreatectomy. One patient received carbon ion radiotherapy and survived 45 months. One patient refused treatment and died 19 months after the diagnosis of SPPDC. Conclusions The incidence rate of SPPDC is not negligible, and the cumulative 5-year incidence rate of SPPDC is markedly high. Post-operative surveillance of the remnant pancreas is critical for the early detection of SPPDC, even in long-term survivors after PDC resection.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Carcinoma, Pancreatic Ductal - epidemiology</subject><subject>Carcinoma, Pancreatic Ductal - pathology</subject><subject>Carcinoma, Pancreatic Ductal - surgery</subject><subject>Cellular biology</subject><subject>Chemotherapy</subject><subject>Disease</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Endoscopy</subject><subject>Female</subject><subject>Funding</subject><subject>Gastroenterology and Hepatology</subject><subject>Humans</subject><subject>Incidence</subject><subject>Kaplan-Meier Estimate</subject><subject>Lymphatic system</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Metachronous</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Neoplasm Recurrence, Local - epidemiology</subject><subject>Neoplasms, Second Primary - epidemiology</subject><subject>Neoplasms, Second Primary - pathology</subject><subject>Neoplasms, Second Primary - surgery</subject><subject>Pancreas</subject><subject>Pancreas - diagnostic imaging</subject><subject>Pancreas - pathology</subject><subject>Pancreatectomy</subject><subject>Pancreatic ductal carcinoma</subject><subject>Pancreatic Neoplasms - epidemiology</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pancreatic Neoplasms - surgery</subject><subject>Pathology</subject><subject>Patients</subject><subject>Remnant pancreatic cancer</subject><subject>Second primary</subject><subject>Sensors</subject><subject>Studies</subject><subject>Surgery</subject><subject>Survival Analysis</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment outcome</subject><subject>Tumors</subject><issn>1424-3903</issn><issn>1424-3911</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ks9u1DAQxi0EoqXwAFyQJS5cNoztOH9AqoQqoEiVOBTOlmPPUi-Js9hJpX0zHo8Ju12kCvXkOfzmG8_3DWMvBRQCRPV2U2xtLCSVBegCQD1ip6KU5Uq1Qjw-1qBO2LOcNwBSCtE-ZSeylqqGtj1lv6_RjdHzbQqDTTtOgi6hnYLjfnaT7bmzyYU4DpaHyKcb5AmHaON0h2Zu1xOmYye6aRx2fD2mh8Te8cvw44a7eZh7Am6R1F3wGB0NIBFSnbjmO7Tp_wOesydr22d8cXjP2PdPH79dXK6uvn7-cvHhauU0yGnVVM6islhrX6MH0Xnyo1OibruuqsFL2fhWQeUkNpUovZfE2qrVZaO1KK06Y2_2uts0_poxT2YI2WHf24jjnI1ooIa6aXVF6Ot76GacU6Tf_aUoDK0kUWJPuTTmnHBtDt4bAWaJ1WwMrWqWWA1oQ7FSz6uD8twN6I8ddzkS8H4PIFlxGzCZ7MJipg-J_DJ-DA_Kn9_rdn2Iwdn-J-4w_9vCZGnAXC93tZyVqBSAlrX6A8VZyyI</recordid><startdate>20160701</startdate><enddate>20160701</enddate><creator>Ishida, Jun</creator><creator>Toyama, Hirochika</creator><creator>Matsumoto, Ippei</creator><creator>Asari, Sadaki</creator><creator>Goto, Tadahiro</creator><creator>Terai, Sachio</creator><creator>Nanno, Yoshihide</creator><creator>Yamashita, Azusa</creator><creator>Mizumoto, Takuya</creator><creator>Ueda, Yuki</creator><creator>Kido, Masahiro</creator><creator>Ajiki, Tetsuo</creator><creator>Fukumoto, Takumi</creator><creator>Ku, Yonson</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8704-4353</orcidid><orcidid>https://orcid.org/0000-0002-8665-2776</orcidid></search><sort><creationdate>20160701</creationdate><title>Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy</title><author>Ishida, Jun ; Toyama, Hirochika ; Matsumoto, Ippei ; Asari, Sadaki ; Goto, Tadahiro ; Terai, Sachio ; Nanno, Yoshihide ; Yamashita, Azusa ; Mizumoto, Takuya ; Ueda, Yuki ; Kido, Masahiro ; Ajiki, Tetsuo ; Fukumoto, Takumi ; Ku, Yonson</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-86cae3ae75d7ed01bd390b3179bb670d228d9306c2e8614dd2ae7a695485514a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Carcinoma, Pancreatic Ductal - epidemiology</topic><topic>Carcinoma, Pancreatic Ductal - pathology</topic><topic>Carcinoma, Pancreatic Ductal - surgery</topic><topic>Cellular biology</topic><topic>Chemotherapy</topic><topic>Disease</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Endoscopy</topic><topic>Female</topic><topic>Funding</topic><topic>Gastroenterology and Hepatology</topic><topic>Humans</topic><topic>Incidence</topic><topic>Kaplan-Meier Estimate</topic><topic>Lymphatic system</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Metachronous</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Neoplasm Recurrence, Local - epidemiology</topic><topic>Neoplasms, Second Primary - epidemiology</topic><topic>Neoplasms, Second Primary - pathology</topic><topic>Neoplasms, Second Primary - surgery</topic><topic>Pancreas</topic><topic>Pancreas - diagnostic imaging</topic><topic>Pancreas - pathology</topic><topic>Pancreatectomy</topic><topic>Pancreatic ductal carcinoma</topic><topic>Pancreatic Neoplasms - epidemiology</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pancreatic Neoplasms - surgery</topic><topic>Pathology</topic><topic>Patients</topic><topic>Remnant pancreatic cancer</topic><topic>Second primary</topic><topic>Sensors</topic><topic>Studies</topic><topic>Surgery</topic><topic>Survival Analysis</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment outcome</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ishida, Jun</creatorcontrib><creatorcontrib>Toyama, Hirochika</creatorcontrib><creatorcontrib>Matsumoto, Ippei</creatorcontrib><creatorcontrib>Asari, Sadaki</creatorcontrib><creatorcontrib>Goto, Tadahiro</creatorcontrib><creatorcontrib>Terai, Sachio</creatorcontrib><creatorcontrib>Nanno, Yoshihide</creatorcontrib><creatorcontrib>Yamashita, Azusa</creatorcontrib><creatorcontrib>Mizumoto, Takuya</creatorcontrib><creatorcontrib>Ueda, Yuki</creatorcontrib><creatorcontrib>Kido, Masahiro</creatorcontrib><creatorcontrib>Ajiki, Tetsuo</creatorcontrib><creatorcontrib>Fukumoto, Takumi</creatorcontrib><creatorcontrib>Ku, Yonson</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ishida, Jun</au><au>Toyama, Hirochika</au><au>Matsumoto, Ippei</au><au>Asari, Sadaki</au><au>Goto, Tadahiro</au><au>Terai, Sachio</au><au>Nanno, Yoshihide</au><au>Yamashita, Azusa</au><au>Mizumoto, Takuya</au><au>Ueda, Yuki</au><au>Kido, Masahiro</au><au>Ajiki, Tetsuo</au><au>Fukumoto, Takumi</au><au>Ku, Yonson</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy</atitle><jtitle>Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]</jtitle><addtitle>Pancreatology</addtitle><date>2016-07-01</date><risdate>2016</risdate><volume>16</volume><issue>4</issue><spage>615</spage><epage>620</epage><pages>615-620</pages><issn>1424-3903</issn><eissn>1424-3911</eissn><abstract>Abstract Objectives The aim of this study was to determine the incidence rate and clinical features of second primary pancreatic ductal carcinoma (SPPDC) in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma (PDC). Methods Data of patients undergoing R0 resection for PDC at a single high-volume center were reviewed. SPPDC was defined as a tumor in the remnant pancreas after R0 resection for PDC, and SPPDC met at least one of the following conditions: 1) the time interval between initial pancreatectomy and development of a new tumor was 3 years or more; 2) the new tumor was not located in contact with the pancreatic stump. We investigated the clinical features and treatment outcomes of patients with SPPDC. Results This study included 130 patients who underwent surgical resection for PDC between 2005 and 2014. Six (4.6%) patients developed SPPDC. The cumulative 3- and 5-year incidence rates were 3.1% and 17.7%, respectively. Four patients underwent remnant pancreatectomy for SPPDC. They were diagnosed with the disease in stage IIA or higher and developed recurrence within 6 months after remnant pancreatectomy. One patient received carbon ion radiotherapy and survived 45 months. One patient refused treatment and died 19 months after the diagnosis of SPPDC. Conclusions The incidence rate of SPPDC is not negligible, and the cumulative 5-year incidence rate of SPPDC is markedly high. Post-operative surveillance of the remnant pancreas is critical for the early detection of SPPDC, even in long-term survivors after PDC resection.</abstract><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>27237099</pmid><doi>10.1016/j.pan.2016.05.003</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-8704-4353</orcidid><orcidid>https://orcid.org/0000-0002-8665-2776</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1424-3903
ispartof Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2016-07, Vol.16 (4), p.615-620
issn 1424-3903
1424-3911
language eng
recordid cdi_proquest_miscellaneous_1807078956
source MEDLINE; Alma/SFX Local Collection
subjects Adult
Aged
Aged, 80 and over
Cancer
Cancer therapies
Carcinoma, Pancreatic Ductal - epidemiology
Carcinoma, Pancreatic Ductal - pathology
Carcinoma, Pancreatic Ductal - surgery
Cellular biology
Chemotherapy
Disease
Endocrinology & Metabolism
Endoscopy
Female
Funding
Gastroenterology and Hepatology
Humans
Incidence
Kaplan-Meier Estimate
Lymphatic system
Male
Medical prognosis
Metachronous
Metastasis
Middle Aged
Mutation
Neoplasm Recurrence, Local - epidemiology
Neoplasms, Second Primary - epidemiology
Neoplasms, Second Primary - pathology
Neoplasms, Second Primary - surgery
Pancreas
Pancreas - diagnostic imaging
Pancreas - pathology
Pancreatectomy
Pancreatic ductal carcinoma
Pancreatic Neoplasms - epidemiology
Pancreatic Neoplasms - pathology
Pancreatic Neoplasms - surgery
Pathology
Patients
Remnant pancreatic cancer
Second primary
Sensors
Studies
Surgery
Survival Analysis
Tomography, X-Ray Computed
Treatment outcome
Tumors
title Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T04%3A35%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Second%20primary%20pancreatic%20ductal%20carcinoma%20in%20the%20remnant%20pancreas%20after%20pancreatectomy%20for%20pancreatic%20ductal%20carcinoma:%20High%20cumulative%20incidence%20rates%20at%205%20years%20after%20pancreatectomy&rft.jtitle=Pancreatology%20:%20official%20journal%20of%20the%20International%20Association%20of%20Pancreatology%20(IAP)%20...%20%5Bet%20al.%5D&rft.au=Ishida,%20Jun&rft.date=2016-07-01&rft.volume=16&rft.issue=4&rft.spage=615&rft.epage=620&rft.pages=615-620&rft.issn=1424-3903&rft.eissn=1424-3911&rft_id=info:doi/10.1016/j.pan.2016.05.003&rft_dat=%3Cproquest_cross%3E4131151651%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1807424532&rft_id=info:pmid/27237099&rft_els_id=1_s2_0_S1424390316300527&rfr_iscdi=true